The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Rheinland-Pfalz; Rheinhessen-Pfalz; Ludwigshafen am Rhein, Kreisfreie Stadt
Location of affected unit(s)
Ludwigshafen
Sector
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
200 jobs Number of planned job losses
Announcement Date
13 May 2014
Employment effect (start)
13 May 2014
Foreseen end date
31 December 2016
Description
US-American pharmaceutical company AbbVie is to cut 200 jobs until 2016 at its site in Ludwigshafen, Germany. As reported, the restructuring is to affect the production sector where 600 people are employed. Job cuts are due to ending contracts for several productions and a low production volume of two HIV drugs. 65 people shall leave the company voluntarily this year.
The president of the works' council was surprised by the amount of the job losses, but a spokesman of the company assured that they are to be implemented in a socially acceptable manner avoiding operational dismissals.
Sources
13 May 2014: SWR.DE
13 May 2014: Mannheimer Morgen
Citation
Eurofound (2014), AbbVie, Internal restructuring in Germany, factsheet number 77023, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/77023.